Dr. Morris has multiple decades of industry experience in the clinical research and development fields. After spending nearly 10 years with GSK as a Senior Director of Oncology, Dr. Morris served as Senior Director at MedImmune and VP of Clinical Development at G1 Therapeutics, where she led trilaciclib through the first indication’s NDA. Dr. Morris received her MD, PhD in molecular virology from Case Western Reserve University School of Medicine and completed her internal medicine residency and oncology fellowship at The University of North Carolina at Chapel Hill.
President & Chief Executive Officer
Chief Medical Officer
Chief Manufacturing Officer
VP, Regulatory Affairs
SVP, Human Resources & Administration
VP, Commercial & Strategic Planning
Chief of Staff and Director, Program Management